Ascendis Pharma
ASND
ASND
154 hedge funds and large institutions have $7.13B invested in Ascendis Pharma in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 65 increasing their positions, 41 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
20% more funds holding in top 10
Funds holding in top 10: 10 → 12 (+2)
5% more funds holding
Funds holding: 147 → 154 (+7)
0.29% less ownership
Funds ownership: 100.83% → 100.54% (-0.29%)
Holders
154
Holding in Top 10
12
Calls
$55.3M
Puts
$17.9M
Top Buyers
| 1 | +$218M | |
| 2 | +$82.5M | |
| 3 | +$34M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$33.7M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$17.2M |
Top Sellers
| 1 | -$255M | |
| 2 | -$59.8M | |
| 3 | -$35M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$30.4M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$27.6M |